Responses
Diabetes and endocrinology
Original research
Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a prospective cohort study (STAR.Ro)
Compose a Response to This Article
Other responses
No responses have been published for this article.